Lv11
12 积分 2023-11-06 加入
The emerging role of Bruton’s tyrosine kinase inhibition in Urticaria Management
31分钟前
待确认
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
1天前
已完结
Nonclinical Safety Signals in PharmaPendium Improve the Predictability of Human Drug-Induced Liver Injury
6天前
已完结
Safety, pharmacokinetics and pharmacodynamics of HWH486 capsules in healthy adults: A randomized, double-blind, placebo-controlled, phase I dose-escalation study
8天前
已完结
02.45 Enhanced bruton's tyrosine kinase activity in peripheral blood b lymphocytes of autoimmune disease patients
8天前
已关闭
Remibrutinib in Chronic Spontaneous Urticaria
29天前
已完结
Early and long-term efficacy and safety of remibrutinib in patients with chronic spontaneous urticaria: 52-week data from the Phase 3 REMIX-1 and REMIX-2 studies
29天前
已完结
Conversion of pathogenic T cells into functionally stabilized T reg cells for antigen-specific immunosuppression in pemphigus vulgaris
1个月前
已完结
Generating functionally stable and antigen-specific T reg cells from effector T cells for cell therapy of inflammatory diseases
1个月前
已完结
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Zanubrutinib in Immune Thrombocytopenia
1个月前
已完结
皖公网安备34019202002308
